CBD research has been ongoing for quite some time after it the initial belief that it did not have any medicinal properties on its own. Ever since the discovery was made that it is an effective method for the treatment of various conditions such as anxiety, pain, and insomnia, the attention CBD has received only continues to increase. This is even more so as CBD has been proven to be able to do much of this without giving users the high that is associated with THC in marijuana. Mr. Smoke is always in the loop about the latest discoveries in the world of CBD and current research could be on the verge of revealing a previously unknown property of it, which is an ability to effectively fight against bacteria.
Before continuing, it is important to note that while many of these results are of a positive nature, they are still very early, and it is not advised to conclude that CBD is an antibiotic. However, in a test environment, researchers have seen where CBD shows much promise in bacteria killing. The research is showing anti-bacterial behavior against some known bacteria types such as staph. More impressively, however, it even seems to have a similar reaction to some bacteria types that have been giving researchers a hard time due to the resistance built up to other forms of bacteria.
Researchers have warned, however, that at this time consumers should not attempt to bypass existing medical channels to treat infections on their own using CBD. Mr. Smoke does NOT advise going against the advice of the research team
The lead author of the study is Mark Blaskovich. Mark is a part of Brisbane, Australia’s Molecular Bioscience Centre for Superbug Solutions, which falls under the University of Queensland. According to Mark, the variety of bacteria that CBD shows promise against is very wide, however, more testing is needed. He did, however, present his current study and findings at the annual meeting of the American Society for Microbiology. The research showed work and results in animals and in test tubes. Should his research be documented in a peer review journal, you may then no longer consider it in its preliminary stages. Blaskovich states that in every case thus far, the bacteria killing potency of CBD is no different from that of many common antibiotics.
The tests were conducted against various strains of staphylococcus. This bacterial family is responsible for infections such as strep throat and various skin ailments. A comparison was then done between CBD’s ability to kill the bacteria and that of common antibiotics already on the market such as Daptomycin and Vancomycin. While both CBD and a drug like Vancomycin show similar results, CDB worked at least twice as fast as it completed killing the bacteria in just three hours compared to Vancomycin’s six to eight-hour timeline.
Another impressive part of the study is the resistance area. Bacteria have been known to build resistances to antibiotics that they encounter over time. CBD, however, showed a much smaller likelihood of causing a resistance build up in the tests.
Blaskovich also stated that CBD seems to be selective for the bacterial type. Therefore, while he found that its use was effective against gram-positive bacteria, it was not the same case with gram-negative bacteria. Be that as it may, gram-positive bacteria is responsible for numerous skin ailments and conditions such as pneumonia. Gram-negative bacteria include E. coli, salmonella, and others.
A separate study by Blaskovich also showed the ability of CBD as a topical agent to provide relief of skin ailments in mice. After 48 hours, the number of bacteria present in the mice was cut significantly, though the infection was not completely cleared. Therefore, that research continues.
Blaskovich indicates that at this point, his team cannot say exactly what CBD does that makes it so effective. Initially, it was thought to be destroying the bacteria by damaging their outer membranes, however, this does not seem to be the case. Therefore, in addition to researching the antibacterial properties, they are also trying to understand what they describe as “a new fighting mechanism.”
Please note that the FDA has only given the green light for CBD to be used for seizure treatment though persons have found many other uses for it with varying degrees of success.